And while expanding facilities are stepping up to serve increasing healthcare needs, the sector’s talent pipeline is also powering up to answer staffing needs. Five of the area’s institutions of higher learning are focused on healthcare training. Five of the top 10 degrees and certifications earned by area graduates are in healthcare-related fields. Collaborations such as the degree agreement between Nevada State University and Touro University enhance training options and ease for prospective healthcare professionals. Meanwhile, Henderson’s quality of life has also been important in recruiting top medical professionals to the area.
The promise of living well, alongside healthy growth, makes the future of Henderson healthcare look promising indeed.
HudsonAlpha Institute For Biotechnology, Huntsville, AL: Nurturing Biotech Companies
Recently ranked number one by U.S. News & World Report as the best place to live in the U.S., Huntsville, Alabama has proven itself to be an inviting and innovative community perfect for fostering the growth and development of individuals and businesses as well as their families. Huntsville is known as the “Rocket City” because it initially boomed thanks to the engineering and aerospace fields. Today, however, the city is also home to a surging biotechnology sector. The sector’s anchor in the region is HudsonAlpha Institute for Biotechnology, a nonprofit organization dedicated to improving the human condition through genomic technology innovation within human health and agriculture.
The Institute has flourished since it was founded in 2008. Home to 50 biotech companies, HudsonAlpha’s 152-acre biotech campus is nestled within Cummings Research Park, the nation’s second largest research park.
Of the companies co-located at HudsonAlpha, one that has seen considerable growth and success is the medical device company, GeneCapture. Using a novel diagnostic technology, GeneCapture has developed a portable device that quickly identifies pathogens like bacteria, viruses, fungi, or protozoa in a patient sample.
“Turnaround time is the barrier with infection detection right now—we’re so tied to the lab,” said Peggy Sammon, CEO and Co-founder of GeneCapture. “Send the sample to the lab, wait for the lab, so if we can get the lab out of the equation, we can move quickly.”
